Collateral License Agreement between GeneLink, Inc. and The University of North Texas Health Science Center at Forth Worth dated July 1, 1996. 2 pages
A Wisconsin Collateral License Agreement is a legal contract entered into between Gentling, Inc. (hereinafter referred to as "Gentling") and The University of North Texas Health Science Center (UNT Health Science Center), outlining the terms and conditions for the licensing and use of intellectual property or collateral materials. This agreement is specifically tailored to comply with the laws and regulations of the state of Wisconsin. The primary purpose of the Wisconsin Collateral License Agreement is to grant Gentling certain rights and access to the intellectual property developed by UNT Health Science Center. These intellectual properties may include patented inventions, copyrights, trade secrets, or any other proprietary information generated by UNT Health Science Center's research and development activities. Keywords: Wisconsin Collateral License Agreement, Gentling, The University of North Texas Health Science Center, intellectual property, collateral materials, licensing, patent, copyright, trade secrets, proprietary information, research and development. There may be different types of Wisconsin Collateral License Agreements that can be established between Gentling and UNT Health Science Center, based on the specific arrangement and purpose of the collaboration. These types can include: 1. Exclusive Collateral License Agreement: In this type of agreement, UNT Health Science Center grants Gentling exclusive rights to use the intellectual property in a specific field or market, prohibiting UNT Health Science Center from licensing the same collateral materials to any other party. 2. Non-Exclusive Collateral License Agreement: This agreement allows UNT Health Science Center to grant collateral licenses to other entities alongside Gentling, thereby enabling multiple parties to utilize the intellectual property simultaneously. 3. Limited Scope Collateral License Agreement: This type of agreement limits Gentling's use of the collateral materials to a specific scope or purpose, distinguishing its application areas more precisely. For example, the agreement may restrict usage to a particular product line or target market. 4. Royalty-based Collateral License Agreement: Under this arrangement, Gentling agrees to pay UNT Health Science Center a percentage or fixed amount of royalties for the commercialization or utilization of the licensed intellectual property. 5. Research Collaboration Collateral License Agreement: This hybrid agreement combines collaboration on research and development activities alongside the licensing of collateral materials. It can entail conducting joint research projects or sharing research findings to obtain further intellectual property rights. Overall, the Wisconsin Collateral License Agreement serves as a crucial legal framework, protecting both Gentling and UNT Health Science Center's interests while facilitating the licensing and utilization of intellectual property in diverse fields, such as biotechnology, healthcare, pharmaceuticals, or other scientific domains.
A Wisconsin Collateral License Agreement is a legal contract entered into between Gentling, Inc. (hereinafter referred to as "Gentling") and The University of North Texas Health Science Center (UNT Health Science Center), outlining the terms and conditions for the licensing and use of intellectual property or collateral materials. This agreement is specifically tailored to comply with the laws and regulations of the state of Wisconsin. The primary purpose of the Wisconsin Collateral License Agreement is to grant Gentling certain rights and access to the intellectual property developed by UNT Health Science Center. These intellectual properties may include patented inventions, copyrights, trade secrets, or any other proprietary information generated by UNT Health Science Center's research and development activities. Keywords: Wisconsin Collateral License Agreement, Gentling, The University of North Texas Health Science Center, intellectual property, collateral materials, licensing, patent, copyright, trade secrets, proprietary information, research and development. There may be different types of Wisconsin Collateral License Agreements that can be established between Gentling and UNT Health Science Center, based on the specific arrangement and purpose of the collaboration. These types can include: 1. Exclusive Collateral License Agreement: In this type of agreement, UNT Health Science Center grants Gentling exclusive rights to use the intellectual property in a specific field or market, prohibiting UNT Health Science Center from licensing the same collateral materials to any other party. 2. Non-Exclusive Collateral License Agreement: This agreement allows UNT Health Science Center to grant collateral licenses to other entities alongside Gentling, thereby enabling multiple parties to utilize the intellectual property simultaneously. 3. Limited Scope Collateral License Agreement: This type of agreement limits Gentling's use of the collateral materials to a specific scope or purpose, distinguishing its application areas more precisely. For example, the agreement may restrict usage to a particular product line or target market. 4. Royalty-based Collateral License Agreement: Under this arrangement, Gentling agrees to pay UNT Health Science Center a percentage or fixed amount of royalties for the commercialization or utilization of the licensed intellectual property. 5. Research Collaboration Collateral License Agreement: This hybrid agreement combines collaboration on research and development activities alongside the licensing of collateral materials. It can entail conducting joint research projects or sharing research findings to obtain further intellectual property rights. Overall, the Wisconsin Collateral License Agreement serves as a crucial legal framework, protecting both Gentling and UNT Health Science Center's interests while facilitating the licensing and utilization of intellectual property in diverse fields, such as biotechnology, healthcare, pharmaceuticals, or other scientific domains.